Philips: InnerCool Stroke Trial Could Lead To $500 Mil. Market Opportunity
This article was originally published in The Gray Sheet
Executive Summary
An international clinical trial using Philips Healthcare's InnerCool endovascular cooling technology to chill the brains of ischemic stroke patients will begin by the end of April